Trials Methodology Research Network

Core Outcome Set–STAndards for Reporting: The COS-STAR Statement

Jamie J Kirkham, Sarah L. Gorst, Douglas G. Altman et al. · PLoS Medicine · 2016 · 605 citations · Full text

Data Analysis and Synthesis Within a Realist Evaluation: Toward More Transparent Methodological Approaches

Brynne Gilmore, Éilish McAuliffe, J. R. Power et al. · International Journal of Qualitative Methods · 2019 · 290 citations · Full text

Complex Health Interventions, Quantitative Methods, Evidence-based Intervention +23

To Cross-Link or Not to Cross-Link? Cross-Linking Associated Foreign Body Response of Collagen-Based Devices

Luis M. Delgado, Yves Bayon, Abhay Pandit et al. · Tissue Engineering Part B Reviews · 2014 · 256 citations · Full text

Mechanobiology, Tissue Engineering, Regenerative Medicine +15

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

Francis J. Giles, Philipp D. le Coutre, Javier Pinilla‐Ibarz et al. · Leukemia · 2012 · 246 citations

Chronic Phase, Hematological Malignancy, Chronic Myeloid Leukemia +6

The trials methodological research agenda: results from a priority setting exercise

Catrin Tudur Smith, Helen Hickey, Mike Clarke et al. · Trials · 2014 · 198 citations · Full text